Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Type 1 diabetes affects 46.3 million people worldwide and the number of people affected is increasing by around 3% each year. This requires careful calculations of insulin requirements and inconvenient daily injections to avoid peripheral disease caused by extremes of high or low blood sugar. Automated insulin delivery systems, also known as artificial pancreas, make … Read more

New technology aims to reduce racial disparities in blood measurements

A team led by a University of Texas at Arlington bioengineering professor and an Austin businessman published key findings in the British Medical Journal Innovations which illustrate how a new device measures hemoglobin more accurately in people with darker skin pigmentations. George Alexandrakis, professor of bioengineering at UT Arlington, and Dr. Vinoop Daggubati of Shani … Read more

New discovery could change the classic model of GPCR-mediated signaling

Researchers from the University of California, San Diego have identified a new signaling process involving G-protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery, published in the October 26, 2022 issue of Natureopens the possibility of new therapies, including for multiple forms of cancer. GPCRs are the largest and … Read more